Figure 4
- ID
- ZDB-FIG-200408-4
- Publication
- Guo et al., 2020 - Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model
- Other Figures
- All Figure Page
- Back to All Figure Page
FHS regulated EMT marker expression in MDA‐MB‐231 cells and TGFβ1‐treated cells. The protein expression of TGFβ1, E‐cadherin, Vimentin, ZEB1, and TWIST1 was determined by Western blotting (A). β‐actin was as an inner control. Target protein expression was normalized against β‐actin protein expression. The mRNA expression of TGFβ1, Snail1, Snail2, ZEB1, and ZEB2 was determined by RT‐qPCR (B). The mRNA level of β‐actin was used as an inner control, and gene‐specific mRNA expression was normalized against β‐actin expression. Control group represents the 20% blank‐control serum group, FHS group represents the 20% Fangjihuangqi Decoction‐medicated serum (FHS), Mod group represents TGFβ1 (10 ng/mL) plus 20% blank‐control serum group, FHS + TGFβ1 group represents 20% FHS plus TGFβ1 (10ng/ml), CDDP + TGFβ1 group represents cisplatin (10 μmol/L) plus TGFβ1 (10 ng/mL) and 20% blank‐control serum group, which was as the positive control, and FHS + CDDP + TGFβ1 group represents 20% FHS plus cisplatin (10 μmol/L) and TGFβ1 (10 ng/mL). ** |